A clinical-stage medical device company developing non-invasive wearable therapeutics for atrial fibrillation (AF)
stimcardio.comLinkedInLos Angeles, CA
LATEST ROUND
Series A
$30M · 2026-10-29
RAISED ON RECORD · USD
$30M
across 1 verified round
INVESTORS
2
1 lead
SOURCES
6
from 4 publishers